Kyoung Eun Joung1,2, Sule Umit Cataltepe1,2, Zoe Michael1,2, Helen Christou1,2,3, Christos S Mantzoros2,4,5. 1. Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115. 2. Harvard Medical School, Boston, Massachusetts 02115. 3. Division of Newborn Medicine, Boston Children's Hospital, Boston, Massachusetts 02115. 4. Division of Endocrinology and Metabolism, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215. 5. Section of Endocrinology, Boston VA Healthcare System, Division of Endocrinology, Jamaica Plain, Massachusetts 02130.
Abstract
Context: Infants born small for gestational age (SGA) have increased risk for obesity and metabolic syndrome, but the underlying mechanisms are not fully elucidated. Adipocyte fatty acid-binding protein (AFABP) is an adipokine that has been implicated in modulation of insulin sensitivity and lipid metabolism. Higher plasma AFABP levels are associated with increased risk of metabolic syndrome and cardiovascular morbidity in adults. Alterations in AFABP levels during fetal growth have not been characterized. Objective: To examine AFABP levels in neonatal cord blood in relation to gestational age and birth weight. Design: A cross-sectional study of 361 neonates born at a tertiary academic center. Outcome Measures: Plasma AFABP levels were measured by enzyme-linked immunosorbent assay. For comparison, venous samples from 26 adults were analyzed. Results: AFABP levels were higher in neonates compared with adults (P < 0.01). Preterm infants had higher AFABP levels [48.2 (31.2 to 73.3) ng/mL] compared with full-term infants [35.8 (25.1 to 51.5)] ng/mL, P < 0.01). There was a negative correlation between AFABP and gestational age (r = 0.28, P = 0.02). Among full-term infants, AFABP levels in SGA infants were lower [28.6 (24.2 to 37.3) ng/mL], compared with appropriate for gestational age [36.1 (25.5 to 50.4) ng/mL] and large for gestational age infants [45.0 (24.6 to 62.4) ng/mL, P < 0.05]. Conclusions: These associations may reflect the higher metabolic activity during fetal development. AFABP may also be involved in fetal growth and the association between SGA status and obesity and metabolic syndrome in later life.
Context:Infants born small for gestational age (SGA) have increased risk for obesity and metabolic syndrome, but the underlying mechanisms are not fully elucidated. Adipocyte fatty acid-binding protein (AFABP) is an adipokine that has been implicated in modulation of insulin sensitivity and lipid metabolism. Higher plasma AFABP levels are associated with increased risk of metabolic syndrome and cardiovascular morbidity in adults. Alterations in AFABP levels during fetal growth have not been characterized. Objective: To examine AFABP levels in neonatal cord blood in relation to gestational age and birth weight. Design: A cross-sectional study of 361 neonates born at a tertiary academic center. Outcome Measures: Plasma AFABP levels were measured by enzyme-linked immunosorbent assay. For comparison, venous samples from 26 adults were analyzed. Results:AFABP levels were higher in neonates compared with adults (P < 0.01). Preterm infants had higher AFABP levels [48.2 (31.2 to 73.3) ng/mL] compared with full-term infants [35.8 (25.1 to 51.5)] ng/mL, P < 0.01). There was a negative correlation between AFABP and gestational age (r = 0.28, P = 0.02). Among full-term infants, AFABP levels in SGA infants were lower [28.6 (24.2 to 37.3) ng/mL], compared with appropriate for gestational age [36.1 (25.5 to 50.4) ng/mL] and large for gestational age infants [45.0 (24.6 to 62.4) ng/mL, P < 0.05]. Conclusions: These associations may reflect the higher metabolic activity during fetal development. AFABP may also be involved in fetal growth and the association between SGA status and obesity and metabolic syndrome in later life.
Authors: Aimin Xu; Annette W K Tso; Bernard M Y Cheung; Yu Wang; Nelson M S Wat; Carol H Y Fong; Dennis C Y Yeung; Edward D Janus; Pak C Sham; Karen S L Lam Journal: Circulation Date: 2007-03-27 Impact factor: 29.690
Authors: Kyung M Choi; Mary Yannakoulia; Min S Park; Geum J Cho; Jung H Kim; Seung H Lee; Taik G Hwang; Sei J Yang; Tai N Kim; Hye J Yoo; Sai H Baik; Seon M Kim; Christos S Mantzoros Journal: Am J Clin Nutr Date: 2010-11-24 Impact factor: 7.045
Authors: Gloria Maria Barraco; Rosa Luciano; Michela Semeraro; Pedro L Prieto-Hontoria; Melania Manco Journal: Int J Mol Sci Date: 2014-10-29 Impact factor: 5.923
Authors: Guoying Wang; Sara Johnson; Yiwei Gong; Sarah Polk; Sara Divall; Sally Radovick; Margaret Moon; David Paige; Xiumei Hong; Deanna Caruso; Zhu Chen; Eric Mallow; Sheila O Walker; Guangyun Mao; Colleen Pearson; Mei-Cheng Wang; Barry Zuckerman; Tina L Cheng; Xiaobin Wang Journal: Sci Rep Date: 2016-07-15 Impact factor: 4.379
Authors: Ellen C Francis; Mengying Li; Stefanie N Hinkle; Jinbo Chen; Jing Wu; Yeyi Zhu; Haiming Cao; Michael Y Tsai; Liwei Chen; Cuilin Zhang Journal: Curr Dev Nutr Date: 2021-09-07
Authors: Żaneta Kimber-Trojnar; Jolanta Patro-Małysza; Marcin Trojnar; Katarzyna E Skórzyńska-Dziduszko; Jacek Bartosiewicz; Jan Oleszczuk; Bożena Leszczyńska-Gorzelak Journal: J Clin Med Date: 2018-12-02 Impact factor: 4.241